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Abstract:
Background:
The vaginal microbiome is influenced by a wide variety of factors, including contraceptive methods.
Aim:
To evaluate the effect of contraceptive methods on vaginal microbiota and to compare MALDI-TOF MS and 16S rDNA sequencing
for lactobacilli identification.
Patients and Methods:
One hundred and one (101) women consulting for birth control were included in a prospective study. Their vaginal content was
sampled and analyzed once  before  they started  using the  contraceptive  method of  their  choice,  and twice  after  the  initiation  of
contraception, at three months (94/101 women attended) and at six months (89/101 women attended). The relative frequencies of
yeasts and trichomonas were analyzed. MALDI-TOF MS and 16S rDNA sequence analysis were applied for the identification of
lactobacilli  in  their  vaginal  microbiota.  The following contraceptive  methods  were  assessed:  Combined Oral  Contraceptive  Pill
(COCP), Condom (CON) and The Rhythm Method (RHYT). McNemar’s statistical test was applied.
Results:
A statistically significant association between COCP and normal microbiota was observed after three months (p< 0.01) and after six
months (p< 0.0001), when the vaginal microbiota was modified. At six months, inflammatory reaction was detected in 3/7 women in
the CON group, while 6/7 patients using RHYT showed the same state. Yeast colonization increased with the COCP. Identification
of lactobacilli by MALDI-TOF MS analysis compared to 16S rDNA sequencing yielded 92.9% concordant results. Lactobacillus
gasseri and L. crispatus were the predominant species.
Conclusion:
The pattern of vaginal states was significantly modified. Hormone administration apparently corrected the alterations  and  retained a
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normal vaginal state. MALDI-TOF MS has the potential of being an  accurate  tool  for  the  identification  of  vaginal lactobacilli
species L. murinus was for the first time isolated from the vagina.
Keywords: Contraception, Basic vaginal states, Vaginal microbiota, Lactobacilli, Probiotic, Immune activation.
1. INTRODUCTION
The vaginal microbiota provides the first line of defense for the lower genital tract. Despite its importance, it is still
necessary to learn more about these microbial communities that vary among individuals or in their composition and
function,  but  more  importantly,  about  how their  constituent  members  interact  with  one  another  to  form a  dynamic
ecosystem that responds to external factors.
The  microenvironment,  with  its  vaginal  microbiota  primarily  regulated  by  a  hormonal  immune  system,  can  be
protected or altered by a wide variety of factors, including contraceptive methods. Some studies reported that combined
oral  contraceptives  are  associated  with  the  stability  of  the  vaginal  microbiota,  while  the  use  of  male  condom  is
associated with Vaginal Inflammatory Reaction (VIR). However, the rhythm method (i.e., sexual abstinence from days
10 to 18) did not produce any significant changes [1 - 4].
Culture-dependent techniques and microscopic observation of the “normal” Vaginal Content (VC) typically show a
predominance of Lactobacillus species, which are believed to promote a healthy vaginal milieu by providing numerical
dominance,  but  also  by  producing  lactic  acid  to  maintain  an  acid  environment,  thus  inhibiting  different  types  of
pathogenic or potentially pathogenic microorganisms, showing a negative correlation with Bacterial Vaginosis (BV)
[5]. Lactobacilli also produce hydrogen peroxide [6], organic acids and bacteriocins [7], and are included in probiotic
products  considered  to  be  beneficial  to  human  health  [8].  It  has  been  demonstrated  that  only  some  specific
Lactobacillus strains express beneficial properties, with differences among species and even among strains within the
same species [9].
Molecular-based  techniques  have  shown  that  a  healthy  vaginal  microbiota  does  not  contain  a  wide  variety  of
Lactobacillus species. One or two lactobacilli from three to four species (mainly L. crispatus, L. jensenii and L. gasseri,
and  in  some  cases  L.  iners)  are  dominant,  whereas  other  species  are  rare,  fewer,  and  apparently  belong  to  novel
phylotypes [10 - 12]. Ravel et al. have published a study in which the production of lactic acid may be conserved in
communities dominated by lactobacilli, and also in communities with low proportion of lactic acid bacteria and high
proportion of strictly anaerobic organisms [13].
Moreover, there are a number of theories that attempt to explain the ecological dynamics of vaginal ecosystems
since they respond to some disturbances caused by human activities such as intercourse, contraceptive practices and
other habits [1 - 4, 14]. This knowledge is required to diagnose and assess the dysbioses of the vaginal tract given their
probable association with inflammatory or immune activation cascades and adverse clinical outcomes like preterm birth
and miscarriage, pelvic inflammatory disease, and the acquisition and transmission of sexually transmitted infections,
including HIV [15].
The aims of this study were to evaluate the effect of contraceptive methods on vaginal microbiota and to compare
MALDI-TOF MS and 16S rDNA sequencing for lactobacilli identification.
2. MATERIALS AND METHODS
This substudy included 101 of 215 women who attended for birth control at a public health care center in Sa Pereira
(Santa  Fe,  Argentina)  from 2013  to  2015.  These  101  women were  selected  at  random to  evaluate  the  influence  of
contraception in two time points, at three months (94/101 women attended) and at six months (89/101 women attended)
and to incorporate the identification of cultivable vaginal Lactobacillus species as a continuation of the research started
in 2013 [3].
The target population ranged in age from 14 to 45 (mean 28.7 years old), was sexually active—from an average of
one to two heterosexual relationships per week—and had a high degree of social homogeneity.
The study was approved by the Ethics Committee of Hospital de Clínicas on July 5, 2013, Buenos Aires, Argentina.
All the women participating in this study signed an informed consent.
Vaginal discharge samples were extracted from the vaginal fornix with swabs at three different times: when the
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women began using the contraceptive method of choice, and three and six months later. Samples were obtained between
days 10 and 20 of the sexual cycle.
Exclusion  criteria  were:  Women  undergoing  local  or  systemic  treatment  with  antibiotics,  antifungals,
corticosteroids,  antiparasitic  drugs  or  immunosuppressants,  and  women  with  some  degree  of  mental  disability.
The study was prospective, consecutive, experimental and descriptive. Vaginal contents were evaluated when the
women began using the method of choice and their BVSs were established by applying the Balance of Vaginal Content
(BAVACO)  methodology  [16].  The  evolution  of  their  BVSs  was  analyzed  according  to  the  type  of  contraceptive
method used.
The BAVACO methodology includes the morphological analysis of the vaginal sample, based on the relationship
between the Numerical Value (NV) using Nugent method and the VIR. The numerical value, which scoring systemis 0
to 10, it was obtained as a weighted combination of the following morphotypes: Gram-positive bacilli compatible with
lactobacilli, gram-variable cocobacilli compatible with Gardnerella and anaerobes and curved gram-variable bacilli. A
VIR was considered positive if there were more than 5 leukocytes (reading in Giemsa, using 1000X). Five BVSs were
defined:  normal  microbiota  (I),  normal  microbiota  with  inflammatory  reaction  (II),  intermediate  microbiota  (III),
bacterial vaginosis (IV) and nonspecific microbial vaginitis (V) (Table 1). The frequency of each BVS was evaluated
according to the contraceptive method used and the relative frequencies of yeasts and trichomonas associated with each
BVS.
Table 1. Criteria for the definition of the basic vaginal states (BVSs).
BVSs in Women in Fertile Age NV VIR
I normal microbiota
Predominance of lactobacilli
0 to 3 No
II normal microbiota + vaginal inflammatory reaction
Predominance of lactobacilli, but presence of vaginal inflammatory reaction
0 to 3 Yes
III intermediate microbiota
Balance between lactobacilli and anaerobic bacteria
4 to 6 No
IV bacterial vaginosis
Predominance of anaerobic bacteria
7 to 10 No
V non-specific microbial vaginitis
Alteration of the lactobacilli/anaerobic bacteria relation, with inflammatory reaction
4 to 10 Yes
BVSs: Basic Vaginal States; NV: Numerical Value (Nugent Criteria); VIR: Vaginal Inflammatory Reaction.
The  women  included  in  the  study  used  the  following  contraceptive  methods  uninterruptedly  for  three  and  six
months:  combined oral  contraceptive pill  (levonorgestrel-ethinylestradiol)  (COCP), condom (CON) and the rhythm
method (RHYT) (i.e., sexual abstinence between days 10 and 18 of the cycle).
The vaginal samples were inoculated into the following culture media (incubated in 5% CO2 atmosphere, for 48
hours):
Columbia base agar (Britania, Argentina) enriched with 5% heme and De-Man, Rogosa and Sharpe agar (MRS,
Biokar Diagnostics, France) to isolate lactobacilli.
Modified  thioglycolate  to  increase  sensitivity  for  detection  of  Trichomonas  vaginalis  after  a  seven-day
incubation period [17].
Chromogenic  medium  for  the  isolation  and  presumptive  differentiation  of  prevalent  Candida  species
(CHROMagar Microbiology, France).
After  the  incubation  conditions  described,  the  isolated  colonies  of  each  medium,  which  were  previously
characterized by their morphology and basic phenotypic properties as gram-positive, catalase-negative bacilli, Strains
were transferred to MRS plates for proteomic and rep-PCR fingerprinting.
All  isolates  from MRS agar  were  analyzed  by  MALDI-TOF MS (Bruker  BD);  using  a  reference  database  that
included over 90 Lactobacillus strains [18]. The identification result was considered reliable when at least the two best
matches (log-score ≥ 1.70) obtained with the MALDI Biotyper database indicated the same species.
Extraction of chromosomal DNA from lactic acid bacteria was carried out according to the modified Pospiech and
Neumann technique [19].  The rep-PCR fingerprinting method was used for clustering the isolated strains using the
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(GTG)  5  primers  [19].  Amplification  reactions  were  performed  in  a  Bio  Rad  My  Cycler  TM  thermocycler.  PCR
products were separated electrophoretically on 1.5% agarose gel. Genomic DNA from selected strains in each cluster
was used for amplification of the 16S rDNA gene using primers MLB and PLB to be later sequenced [20]. For species
identification, the 16S rDNA sequences were compared considering a homology percentage higher than 98%. rRNA
gene sequence alignments were performed using the multiple sequence alignment method and identification queries
were fulfilled by a BLAST search in GenBank (http://www.ncbi.nlm.nih.gov/GenBank/).
2.1. Statistical Analyses
The evolution of the frequency of the BVSs in the COCP group was analyzed with McNemar’s test. A p value <
0.05 was considered statistically significant. The Kappa index was calculated as a measure of agreement between the
sequencing of the 16S rDNA gene and MALDI-TOF MS for the identification of lactobacilli.
3. RESULTS
3.1. Distribution of the Basic Vaginal States According to the Contraception Method
The  basal  set  of  test  results  obtained  from  the  101  women  included  in  the  study  before  they  started  using  the
contraceptive method of their choice was as follows: 55 (54.5%) showed BVS I, 16 (15.8%) BVS II, 3 (3%) BVS III,
17 (16.8%) BVS IV and 10 (9.9%) BVS V. Fig.  (1)  shows the distribution and follow-up of the study participants
according to the contraceptive method, at the beginning of the study and after three and six months of use.
Fig. (1). Follow up of the study participants.
After three months of contraception, 94/101 women attended and fulfilled the initial study and the evaluation at
three months. When the changes in the vaginal microbiota were considered, independently of the variation in VIR, 53
patients  maintained  BVSs  with  normal  vaginal  microbiota  (BVS  I  and  II)  and  10  of  the  25  women  with  vaginal
dysfunction  before  starting  the  COCP  reverted  to  normal  vaginal  microbiota  (conversion  to  BVS  I  and  II).  These
changes  showed a  statistically  significant  association  between  the  COCP and  normal  vaginal  microbiota  (p=  0.01)
(Table 2). Of the 7 women who chose the use of condom, 2 evidenced VIR (conversion to BVS II), while the remaining
COCP: combined oral contraceptive pill (levonorgestrel-ethinylestradiol) 
CON: condom 
RHYT: rhythm method
COCP group: n = 84
They did not attend the consultation: n = 5
Analyzed:  n = 79
Total women included at the beginning
of the study: n 101
At three
months
n=94
At six
months
n=89
CON group: n = 8
They did not attend the consultation: n = 1
Analyzed:   n = 7
RHYTH group: n = 9
They did not attend the consultation: n = 1
Analyzed:  n = 8
COCP group: n = 84
They did not attend the consultation: n = 9
Analyzed:  n = 75
RHYTH group: n = 9
They did not attend the consultation: n = 2
Analyzed:  n = 7
CON group: n = 8
They did not attend the consultation: n = 1
Analyzed:  n = 7
222   The Open Microbiology Journal, 2018, Volume 12 Fosch et al.
maintained an altered BVS (Table 2). Of the 8 patients who chose the rhythm method, 7 maintained their initial BVS
(Table 2).
Table  2.  Evaluation  of  three  months  of  contraception:  Distribution  of  basic  vaginal  states  (BVSs)  according  to  the
contraception  method.
BVS1
COCP 2 CON 3 RHYT 4
Initial Study
Distribution of
BVS (n)
After 3 Months
Conversion to BVS
Analyzed n= 79
Initial Study
Distribution of
BVS (n)
After 3 Months
Conversion to BVS
Analyzed n= 7
Initial Study
Distribution of
BVS (n)
After 3 Months
Conversion to
BVS
Analyzed n= 8
I normal microbiota 41
I = 34
II = 7
3
I = 2
II = 1
5 I = 5
II
normal microbiota +VIR
13
*(2/13)
I = 2
II = 10
III = 1
2 II = 2 2
I = 1
II = 1
III
intermediate microbiota
2
I = 1
III = 1
1 II = 1 - -
IV
bacterial vaginosis
16
*(1/16)
I = 3
II = 2
IV = 11
- - 1 IV = 1
V
non-specific microbial
vaginitis
7
*(7/7)
I = 1
II = 3
IV = 2
V = 1
1 V = 1 - -
TOTAL 79
Conversion to BVS I –
II of microbiota normal
= 10
7
Conversion
to BVS II with VIR
= 2
8 -
1BVSs: Basic Vaginal States -  2COCP: Combined Oral Contraceptive Pill  (levonorgestrel-ethinylestradiol)  -  3CON: Condom - 4RHYT: Rhythm
Method -*Metronidazole Treatment.
Table 3. Evaluation of six months of contraception: Distribution of basic vaginal states (BVSs) according to the contraception
method.
BVS1
COCP 2 CON 3 RHYT 4
Initial Study
Distribution of
BVS (n)
After 6 Months
Conversion to BVS
Analyzed n= 75
Initial Study
Distribution of
BVS (n)
After 6 Months
Conversion to BVS
Analyzed n= 7
Initial Study
Distribution of
BVS (n)
After 6 Months
Conversion to
BVS
Analyzed n= 7
I
normal microbiota
41
I = 33
II = 7
IV = 1
4
I = 2
II = 2
4 I = 4
II
normal microbiota +VIR
10
I = 6
II = 4
1 II = 1 2
I = 1
II = 1
III
intermediate microbiota
1 I = 1 1 II = 1 - -
IV
bacterial vaginosis
14
I = 8
II = 4
IV = 2
- 1 IV = 1
V
non-specific microbial
vaginitis
9
I = 6
II = 2
IV = 1
1 V = 1 - -
TOTAL 75
Conversion to BVS I –
II of microbiota normal
= 21
7
Conversion
to BVS II with
VIR= 3
7 -
1BVSs: Basic Vaginal States -  2COCP: Combined Oral Contraceptive Pill  (levonorgestrel-ethinylestradiol)  -  3CON: Condom - 4RHYT: Rhythm
Method -*Metronidazole Treatment
After six months of contraception, 89/101 women attended and fulfilled the initial study and the evaluation at six
months. When the changes in the vaginal microbiota were evaluated, independently of the variation in VIR, we found
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that 50 patients maintained BVSs with normal vaginal microbiota (BVS I and II), and 21 of 24 women with vaginal
dysfunction before starting the COCP reverted to normal vaginal microbiota (conversion to BVS I and II). These results
showed a statistically significant association between the COCP and normal vaginal microbiota (p< 0.0001) (Table 3).
Of the 7 women using condom, 3 showed VIR (conversion to BVS II), which was not present at the beginning of the
study (Table 3). Of the 7 patients who used the rhythm method, 6 retained their initial BVSs (Table 3).
The distribution of the BVSs in the COCP group after three and six months is shown in Fig. (2). An increase is
observed in BVS I and II with normal microbiota and a decrease is seen in BVS IV and V with altered microbiota.
Fig. (2). Basic Vaginal States (BVS): Conversion by hormonal contraception.
3.2. Distribution of Yeasts Associated with Basic Vaginal States
In the first evaluation before starting the COCP, yeasts were detected in 25/79 samples. Three months later, the
proportion  of  yeasts  was  22/79,  but  yeasts  were  found  in  7/22  samples  that  had  not  presented  any  yeasts  at  the
beginning of the study (4 with BVS I and 3 with BVS II). It should be noted that only 6 symptomatic women were
treated with antifungals (Table 4).
Before the use of CON, yeasts were detected in only 1/7 sample with BVS II, which remained unchanged after three
months. In the RHYT group, at the beginning yeasts were found in 3/8 samples with BVSs I (2) and II (1); after three
months, yeasts were observed in one sample with BVS I.
In  the  first  evaluation  before  starting  the  COCP,  yeasts  were  detected  in  19/75  samples.  Six  months  later,  the
proportion  of  yeasts  was  12/75,  but  yeasts  were  found  in  3/12  samples  that  had  not  presented  any  yeasts  at  the
beginning of the study (1 with BVS I and 2 with BVS II) (Table 4).
Before the use of CON, yeasts were detected in only 1/7 sample with BVS II, which remained unchanged after six
months. In the RHYT group, at the beginning yeasts were found in 3/8 samples with BVSs I (2) and II (1); after six
months no yeasts were detected.
BVS I BVS II BVS III BVS IV BVS V
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
100.0%
51
.9
%
16
.5
%
2.
5%
20
.2
%
8.
9%
51
.9
%
27
.8
%
2.
5%
16
.5
%
1.
3%
72
.0
%
22
.7
%
5.
3%
Beginning Three months Six months
% of patients
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Table 4. Distribution of yeasts associated with basic vaginal states (BVSs) at 3 and 6 months after the initiation of COCP.
BVS1
COCP 2
Yeast Detection
Analyzed n = 79
Yeast Detection
Analyzed n = 75
Evaluation of Three Months of Contraception Evaluation o Six Months of Contraception
Initial Study (n) After 3 Months (n) Initial Study (n) After 6 Months (n)
I
normal microbiota
11
8
4/8**
9
5
1/5**
II
normal microbiota + vaginal inflammatory reaction
9
(4/9)*
13
3/13**
6
7
2/7**
III
intermediate microbiota
1 - - -
IV
bacterial vaginosis
2 - 2 -
V
non-specific microbial vaginitis
2
(2/2)*
1 2 -
total 25 22 19 12
1BVSs: Basic Vaginal States 2COCP: Combined Oral Contraceptive Pill (Levonorgestrel-Ethinylestradiol) *Treated with antifungals **Undetected at
the beginning of contraceptive method used
3.3. Distribution of Trichomonas vaginalis Associated with Basic Vaginal States
Trichomonas were detected in 11 of the 101 women at the beginning of the study who consulted for the use of
COCP and had BVS II (3) and BVS V (8). The 11 patients started treatment (metronidazole 1000 mg daily for seven
days) and contraception with COCP. After three months, the parasite was absent in the 8/11 patients attended. After six
months, the parasite was absent and the normal vaginal microbiota was restored in the 11 patients (BVS I and BVS II).
Trichomonas were not detected in the women who consulted for CON and RHYT.
3.4. Lactobacillus Species in Vaginal Contents
Eighty-four Lactobacillus strains were isolated and identified: 23/84 from 94 vaginal content samples obtained after
three months and 61/84 from 89 vaginal content samples obtained after six months of initiating contraception. The
genomic and proteomic identification were performed for all the lactobacilli isolates.
Table  5.  Degree  of  agreement  in  the  identification  of  lactobacilli  with  MALDI-TOF  MS  and  Rep-PCR  genomic
fingerprinting.
Identification Methodology MALDI-TOF MS
Rep-PCR genomic fingerprinting
Lactobacillus species
L. crispatus
(n)
L. gasseri
(n)
L. jensenii
(n)
L. johnsonii
(n)
L. murinus
(n)
L. crispatus
(n)
25 - - - -
L. gasseri
(n)
1 27 5 - -
L. jensenii
(n)
- - 15 - -
L. johnsonii
(n)
- - - 1 -
L. murinus
(n)
- - - - 10
Kappa Coefficient: 0.901(excellent degree of concordance)
Confidence interval Kappa SE(0): (0.775, 1.028)
Confidence interval Kappa SE(1): (0.826, 0.977)
The two methods applied showed concordant results in 78 (92.9%) of the isolates. Of these, 27 (34.6%) strains were
identified as L. gasseri, 25 (32.1%) as L. crispatus, 15 (19.2%) as L. jensenii, 10 (12.8%) as L. murinus and 1 (1.3%) as
L. johnsonii. The Kappa concordance correlation coefficient obtained between the two methods was 0.901 (Table 5).
Fig. (3) shows the different biotypes of the strains obtained during the identification of lactobacilli by rep-PCR assays,
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that  indicates  the  patterns  of  all  the  biotypes,  eventhough  they  were  not  the  dominant  species  in  the  study.  One
representative from each biotype was identified by partial 16S rRNA gene sequencing.
Fig. (3). Representative biotypes obtained from Random amplified polymorphic DNA (RAPD)-PCR profiles of lactic acid bacteria
(LAB) isolated from vaginal samples. Primers (GTG)5 were used for RAPD-PCR analysis. MW: Molecular weight marker (1kb
DNA ladder, Invitrogen). (GTG)5 RAPD profiles including the following biotypes: Bt1 (L. crispatus,); Bt2 (L. gasseri); Bt3 (L.
jensenii); Bt4 (L. mucosae); Bt5 (L. johnsonii); Bt6 (L. murinus); Bt7 (L. oris); Bt8 (Lc. mesenteroides); Bt9 (L. acidophilus); Bt10
(E. faecium) Bt11 (W. paramesenteroides) and Bt12 (S. epidermidis). Methods are described in the text.
In 7.1% (6/84) of the cases, the results were discordant: 83.3% of these discordances were among related species L.
gasseri and L. jensenii, and 16.7% among L. gasseri and L. crispatus (Table 5). The species that were isolated in a
higher proportion were L. gasseri and L. crispatus. The former was isolated from 88.9% of healthy women and 11.1%
with bacterial vaginosis (BVS IV). L. crispatus was associated with normal vaginal microbiota (100%) and 84% of the
strains were isolated from the group of women who chose COCP. L. murinus was first isolated from the vagina and in a
remarkable proportion.
4. DISCUSSION
The uninterrupted use of COCP in both periods (three and six months) did not only maintain the normal microbiota,
but  also  decreased  the  frequency  of  bacterial  vaginosis.  The  hormonal  contribution  of  COCP,  although  it  is  an
“external” factor, represents one of the main regulators of the hormonal action and, therefore, supports the hypothesis of
the effect  of  estrogen on the vaginal  state.  Similar  results  were described in a  few recent  studies,  which have only
reported the effect of hormones [2].
One  of  the  mechanisms  of  protection  demonstrated,  both  for  endogenous  and  exogenous  sex  hormones,  is  the
hormonal effect on the vaginal mucosa through the cell receptors. These receptors stimulate the multiplication of the
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epithelium and thus help the production of adequate glycogen concentration in intermediate cells. Estrogen stimulation
produces  a  predominance  of  surface  layer  cells,  whereas  progesterone  stimulation  produces  a  predominance  of
intermediate layer cells [21]. In response to hormonal variations, the lysis of the latter cells generates glycogen, thus
favoring the survival of lactobacilli and the maintenance of a protective pH [22 - 24]. In addition, recent studies have
documented  another  hormone-dependent  protection  mechanism through  an  activity  of  proton  pumping  (by  an  H+-
ATPase) in the apical membrane of vaginal and cervical epithelium cells stimulated by estrogen, which decreases at
menopause, with the consequent increase in vaginal pH [25].
However, the results of this research indicate that the use of COCP promoted yeast colonization in healthy women,
since the highest proportion was obtained after three months of consumption, with new carriers detected at three months
with BVS I and BVS II, in agreement with our group previously studied and with other authors [1 - 3]. Nevertheless, it
cannot be ruled out that this colonization represents a predisposing condition for recurrent vulvovaginitis.
It  is  well  known  that  physiological  and  pharmacological  hyperestrogenemia  is  associated  with  higher  yeast
colonization in the vagina,  which could result  from certain mechanisms directly mediated by estrogens,  mainly the
increase in vaginal glycogen, the reduction of vaginal pH and easier adhesion to epithelial cells. Although this subject
has been under study for many years, it remains a controversial issue.
In the Trichomonas vaginalis carrier group, after six months, a Lactobacillus-dominated vaginal microbiota was
recovered with the combined treatment of metronidazole and hormonal contraceptives, in addition to the absence of the
parasite. Acting as vaginal sentinels and biomarkers, the predominance of Lactobacillus determined the consistency
between clinical and microbiological cure rates.
The fact that condoms were used by a low percentage of the women did not allow a comparative analysis with
COCP. This study highlights instead that the use of male condoms demonstrated conversion to BVS with VIR (BVS II
and BVS V). These results are consistent with previous reports that have shown the presence of vaginal dermatitis,
allergic and irritant vulvovaginitis, and inflammation associated with the use of condoms, due to the influence of either
the latex or the spermicide [4]. It must be considered that the vulvar mucosa is nonkeratinized epithelia and the moisture
in which it is immersed promotes the penetration of irritants and allergens, thus generating vaginitis states [26].
With  regard  to  the  rhythm method,  the  reduced  number  of  women  (7/101)  adopting  this  contraceptive  method
makes it difficult to draw a conclusion or to refer to the results of other researches. However, the balance of the vaginal
microbiota  turned  out  to  be  surprising.  The  vaginal  microenvironment  of  these  women  is  only  under  the  systemic
hormonal influence during the ovulation stage, which favors the growth of lactobacilli and preserves normal microbiota.
Also  during  the  sexual  abstinence  period,  there  is  no  exposure  to  semen  or  leukocytes  as  modifiers  of  the  vaginal
environment, and therefore it remains stable and normal for longer.
Although with the condom and the rhythm method no significant changes were detected in the proportion of yeasts,
due to the small size of both groups, it is necessary to continue the study with a larger number of women to evaluate the
influence.
The closely related species within the L. acidophilus complex are difficult to differentiate by phenotypic methods,
which  may  account  for  the  variation  in  Lactobacillus  species  or  clusters  associated  with  the  vaginal  microbiota
published  by  different  authors  (20).  The  culture  in  a  specific  medium only  detects  some  fastidious  organisms  and
underestimates the diversity of the vaginal microbiome; however, it allows detecting the predominant genus or species,
studying the expression of defensive properties and relating them to different conditions of the vaginal microbiota. It is
important to identify lactobacilli to evaluate the role of the different Lactobacillus species, particularly in relation to
their ability to produce H2O2 and to function as probiotics. We must recognize that our results are limited and biased
because  certain  microbial  species,  mainly  L.  iners,  do  not  grow  easily  in  laboratory  conditions.  Under  most
circumstances,  normal  vaginal  microbiota  is  dominated  by  Lactobacillus  species.  Based  on  the  hypothesis  of
“competitive exclusion” and “bacterial interference” mechanisms, when lactobacilli dominate the vaginal microbiota,
culture-independent techniques have shown, and also in this work, that a healthy vagina is usually colonized by only
one or two dominant Lactobacillus species, mainly L. crispatus, L. gasseri and L. jensenii. The dominant Lactobacillus
species may differ racially or geographically, but the principle of numerical dominance continues and could act as a
main  defense  mechanism  [13,  27].  The  finding  of  L.  murinus  for  the  first  time  in  the  vagina  and  in  a  significant
percentage could reflect the relationship between species and geographical locations. In this work, 8 of the 10 carriers
of this species are rural workers on dairy farms and consumers of unpasteurized milk, which could explain the detection
of this species in the samples.
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In this study, MALDI-TOF MS analysis showed 92.9% concordant results with 16S rDNA sequencing applied to
identify lactobacilli isolates from vaginal samples at the species level. Consequently, mass spectrometry proved to be an
accurate  and  fast  method  to  identify  vaginal  lactobacilli  species.  Other  studies  comparing  mass  spectrometry  with
genotypic methods have reported a greater concordance percentage (96%) [28], a similar concordance percentage (93%)
[29] and lower values (74%) [30] in comparison to our results. Most of the discordant results can be explained by the
fact that L. gasseri, L. jensenii and L. crispatus are phylogenetically closely related species. The phylogenetic analysis
supports the sequence similarity.  The combination of 16S rDNA sequencing and MALDI-TOF MS revealed a new
species associated with the vaginal microbiota, L. murinus.
The isolation of L. gasseri in women with bacterial vaginosis (BVS IV) suggests specific areas for future research,
such  as  assessing  the  potential  role  of  L.  gasseri  in  bacterial  vaginosis  pathogenesis  [31].  Besides,  the  association
between L. crispatus and normal microbiota (100%) agrees with the results of Marrazzo et al. and is supported by the
protective properties of L. crispatus to maintain a healthy microenvironment [31].
CONCLUSION
The  pattern  of  vaginal  states  was  significantly  modified  according  to  the  type  of  contraceptive  method  used.
Hormone administration apparently corrected the alterations and preserved a normal vaginal state. MALDI-TOF MS
has the potential of being an accurate tool for vaginal lactobacilli species identification in concordance with 16sr-DNA
sequencing. L. murinus was for the first time isolated from the vagina and may reflect the relationship of the species
with geographical locations.
LIST OF ABBREVIATIONS
COCP = Combined Oral Contraceptive Pill
CON = Condom
RHYT = Rhythm Method
VIR = Vaginal Inflammatory Reaction
BVSs = Basic Vaginal States
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
The study was approved by the Ethics Committee of Hospital de Clínicas on July 5, 2013, Buenos Aires, Argentina.
HUMAN AND ANIMAL RIGHTS
Animals did not participate in this research. All human research procedures followed were in accordance with the
ethical standards of the committee responsible for human experimentation (institutional and national),  and with the
Helsinki Declaration of 1975, as revised in 2008.
CONSENT FOR PUBLICATION
All the women participating in this study signed an informed consent.
CONFLICT OF INTEREST
The authors declare no conflict of interest, financial or otherwise.
ACKNOWLEDGEMENTS
The authors are grateful to Prof. Dr. Ramon De Torres for his persistent help and motivation.
REFERENCES
[1] Gupta K, Hillier SL, Hooton TM, Roberts PL, Stamm WE. Effects of contraceptive method on the vaginal microbial flora: A prospective
evaluation. J Infect Dis 2000; 181(2): 595-601.
[http://dx.doi.org/10.1086/315267] [PMID: 10669343]
[2] Vodstrcil LA, Hocking JS, Law M, et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: A systematic review
and meta-analysis. PloS ONE8 2013; 8(9): e 73055.
[http://dx.doi.org/10.1371/journal.pone.0073055]
[3] Fosch S, Yones C, Trossero M, Grosso O, Perazzi B. Influence of contraception on basic vaginal states: A prospective study. Health 2015; 7:
228   The Open Microbiology Journal, 2018, Volume 12 Fosch et al.
238-44.
[http://dx.doi.org/10.4236/health.2015.72028]
[4] Schreiber CA, Meyn LA, Creinin MD, Barnhart KT, Hillier SL. Effects of long-term use of nonoxynol-9 on vaginal flora. Obstet Gynecol
2006; 107(1): 136-43.
[http://dx.doi.org/10.1097/01.AOG.0000189094.21099.4a] [PMID: 16394051]
[5] Skarin A, Sylwan J. Vaginal lactobacilli inhibiting growth of Gardnerella vaginalis, Mobiluncus and other bacterial species cultured from
vaginal content of women with bacterial vaginosis. Acta Pathol Microbiol Immunol Scand 1986; 94(6): 399-403.
[PMID: 3494379]
[6] Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996;
174(5): 1058-63.
[http://dx.doi.org/10.1093/infdis/174.5.1058] [PMID: 8896509]
[7] Aroutcheva AA, Simoes JA, Faro S. Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inhibits Gardnerella vaginalis.
Infect Dis Obstet Gynecol 2001; 9(1): 33-9.
[http://dx.doi.org/10.1155/S1064744901000060] [PMID: 11368257]
[8] Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: Recent advances. Inflamm Bowel Dis 2009; 15(2):
300-10.
[http://dx.doi.org/10.1002/ibd.20602] [PMID: 18626975]
[9] Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 1999; 65(9): 3763-6.
[PMID: 10473372]
[10] Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women
using cultivation-independent methods. Microbiol 2004; 150(Pt 8): 2565-73.
[http://dx.doi.org/10.1099/mic.0.26905-0] [PMID: 15289553]
[11] Pavlova SI, Kilic AO, Kilic SS, et al. Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene
sequences. J Appl Microbiol 2002; 92(3): 451-9.
[http://dx.doi.org/10.1046/j.1365-2672.2002.01547.x] [PMID: 11872120]
[12] Zhou X, Brown CJ, Abdo Z, et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black
women. ISME J 2007; 1(2): 121-33.
[http://dx.doi.org/10.1038/ismej.2007.12] [PMID: 18043622]
[13] Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2011; 108(Suppl. 1): 4680-7.
[http://dx.doi.org/10.1073/pnas.1002611107] [PMID: 20534435]
[14] Hickey RJ, Zhou X, Pierson JD, Ravel J, Forney LJ. Understanding vaginal microbiome complexity from an ecological perspective. Transl
Res 2012; 160: 267-82.
[http://dx.doi.org/10.1016/j.trsl.2012.02.008]
[15] Jespers V, Kyongo J, Joseph S, et al. A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-
Saharan Africa. Sci Rep 2017; 7(1): 11974.
[http://dx.doi.org/10.1038/s41598-017-12198-6] [PMID: 28931859]
[16] Ortega Soler C, Castaño R, Copolillo E, et al.  Guía práctica integral (Clínica-Laboratorio) de diagnóstico de vaginosis y vaginitis en la
atención primaria de la (MEF). Acta Bioquim Clin Latinoam 2010; 44: 359-69.
[17] Perazzi  BE, Menghi CI,  Coppolillo EF, et  al.  Prevalence and comparison of diagnostic methods for  Trichomonas vaginalis  infection in
pregnant women in Argentina. Korean J Parasitol 2010; 48(1): 61-5.
[http://dx.doi.org/10.3347/kjp.2010.48.1.61] [PMID: 20333287]
[18] Karas M, Krger R. Ion formation in MALDI: The cluster ionization mechanism. Chemical Reviews 2003; 103: 427440.
[http://dx.doi.org/10.1021/cr010376a]
[19] Gevers D, Huys G, Swings J. Applicability of rep-PCR fingerprinting for identification of Lactobacillus species. FEMS Microbiol Lett 2001;
205(1): 31-6.
[http://dx.doi.org/10.1111/j.1574-6968.2001.tb10921.x] [PMID: 11728712]
[20] Kullen MJ, Sanozky-Dawes RB, Crowell DC, Klaenhammer TR. Use of the DNA sequence of variable regions of the 16S rRNA gene for
rapid and accurate identification of bacteria in the Lactobacillus acidophilus complex. J Appl Microbiol 2000; 89(3): 511-6.
[http://dx.doi.org/10.1046/j.1365-2672.2000.01146.x] [PMID: 11021584]
[21] Hans FN. Citodiagnóstico ginecológico (1ª Edición). Buenos Aires: Médica Paramericana 2004.
[22] Levin RJ. Measuring female genital functions-A research essential but still a clinical luxury? Sex Relationship Ther 2004; 19: 191-200.
[http://dx.doi.org/10.1080/14681990410001691406]
[23] Huggins GR, Preti G. Vaginal odors and secretions. Clin Obstet Gynecol 1981; 24(2): 355-77.
[http://dx.doi.org/10.1097/00003081-198106000-00005] [PMID: 7030563]
[24] Boskey ER, Cone RA, Whaley KJ, Moench TR. Origins of vaginal acidity: High D/L lactate ratio is consistent with bacteria being the primary
source. Hum Reprod 2001; 16(9): 1809-13.
[http://dx.doi.org/10.1093/humrep/16.9.1809] [PMID: 11527880]
Contraception: Influence on Microbiota and Identification of Vaginal Lactobacilli The Open Microbiology Journal, 2018, Volume 12   229
[25] Gorodeski GI, Hopfer U, Liu CC, Margles E. Estrogen acidifies vaginal pH by up-regulation of proton secretion via the apical membrane of
vaginal-ectocervical epithelial cells. Endocrinol 2005; 146(2): 816-24.
[http://dx.doi.org/10.1210/en.2004-1153] [PMID: 15498880]
[26] Moraes PS, Taketomi EA. Allergic vulvovaginitis. Ann Allergy Asthma Immunol 2000; 85(4): 253-65.
[http://dx.doi.org/10.1016/S1081-1206(10)62527-6] [PMID: 11061467]
[27] Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome: New information about genital tract flora using molecular based techniques.
BJOG 2011; 118(5): 533-49.
[http://dx.doi.org/10.1111/j.1471-0528.2010.02840.x] [PMID: 21251190]
[28] Anderson AC, Sanunu M, Schneider C,  et  al.  Rapid species-level  identification of vaginal  and oral  lactobacilli  using MALDI-TOF MS
analysis and 16S rDNA sequencing. BMC Microbiol 2014; 14: 312-5.
[http://dx.doi.org/10.1186/s12866-014-0312-5] [PMID: 25495549]
[29] Callaway A, Kostrzewa M, Willershausen B, et al. Identification of Lactobacilli from deep carious lesions by means of species-specific PCR
and MALDI-TOF mass spectrometry. Clin Lab 2013; 59(11-12): 1373-9.
[PMID: 24409673]
[30] Dušková  M,  Šedo  O,  Kšicová  K,  Zdráhal  Z,  Karpíšková  R.  Identification  of  lactobacilli  isolated  from food  by  genotypic  methods  and
MALDI-TOF MS. Int J Food Microbiol 2012; 159(2): 107-14.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2012.07.029] [PMID: 23072695]
[31] Marrazzo JM, Antonio M, Agnew K, Hillier SL. Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis 2009;
199(5): 680-3.
[http://dx.doi.org/10.1086/596632] [PMID: 19199538]
© 2018 Fosch et al.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a
copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and
reproduction in any medium, provided the original author and source are credited.
